Posted On: 03/17/2014 7:34:11 AM
Post# of 63854
- Alliance Data Provides Private Label Performance Update For February 2014
- TeleCommunication Systems and Patent Monetization Associates, L.P. Sign Patent Agreement
- AMN Healthcare Invests in Leading Telepharmacy Company PipelineRx
- GFI Development Company Adopts Submittal Exchange on Iconic Five Beekman Street Project
- Dril-Quip Awarded Contract For The Supply Of Subsea Completion Systems
- Maple Leaf Foods Issues Notice of Repayment for $706 million Senior Notes
- Launch of the Legrand Foundation
- Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development
- Ball Aerospace Powers On Joint Polar Satellite System (JPSS-1) Spacecraft
- Domino's Pizza® Kicks Off College Basketball's Biggest Month with 50 Percent Off Pizza Deal
- Eurozone inflation in surprise fall to 0.7 percent
- Yingli Green Energy Supplies 10 MW of PV Modules to Solarcentury in the United Kingdom
- Cascades to present at the Goldman Sachs Conference
- China Sunergy to Announce Fourth Quarter and Full-Year 2013 Results on Friday, April 4, 2014
- Well Power, Inc. Analyst Report: Intriguing Early Technology Play - Results Required Before Considering Investment, by BrokerBank Securities, Inc.
- VIASPACE Giant King Grass Released from Quarantine in Hawaii
- IBM Study: CMOs Fusing Internal and External Data to Drive Financial Success
- Augusta responds to extension of HudBay offer and waiver of minimum tender condition
- Village Farms International Announces Year End 2013 Results
- Lucas Energy Submits Plan Of Compliance To NYSE MKT
- TVI Pacific Inc. Announces First Nickel Production from Pilot Plant
- Fortune 500 Executive Joins Spherix as Vice President, Licensing
- Invoca Enhances Enterprise Inbound Call Platform and Expands Addressable Market with Level 3 Voice Solutions
- Advanced Cannabis Solutions Analyst Review, by BrokerBank Securities, Inc.
- ?Can-Fite: Phase II Study Protocol to Treat Patients with Advanced Liver Cancer with CF102 has been Approved by the IRB in Israel
(0)
(0)
